H-gemcitabine: a new gemcitabine prodrug for treating cancer
about
Synthesis and cytostatic evaluation of 4-N-alkanoyl and 4-N-alkyl gemcitabine analogues.Preclinical Evaluation of Radioiodinated Hoechst 33258 for Early Prediction of Tumor Response to Treatment of Vascular-Disrupting Agents.The 4-N-acyl and 4-N-alkyl gemcitabine analogues with silicon-fluoride-acceptor: Application to 18F-Radiolabeling.Hoechst 33258–conjugated hyaluronated fullerene for efficient photodynamic tumor therapy and necrotic tumor targeting
P2860
H-gemcitabine: a new gemcitabine prodrug for treating cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
H-gemcitabine: a new gemcitabine prodrug for treating cancer
@ast
H-gemcitabine: a new gemcitabine prodrug for treating cancer
@en
H-gemcitabine: a new gemcitabine prodrug for treating cancer.
@nl
type
label
H-gemcitabine: a new gemcitabine prodrug for treating cancer
@ast
H-gemcitabine: a new gemcitabine prodrug for treating cancer
@en
H-gemcitabine: a new gemcitabine prodrug for treating cancer.
@nl
prefLabel
H-gemcitabine: a new gemcitabine prodrug for treating cancer
@ast
H-gemcitabine: a new gemcitabine prodrug for treating cancer
@en
H-gemcitabine: a new gemcitabine prodrug for treating cancer.
@nl
P2093
P2860
P50
P356
P1476
H-gemcitabine: a new gemcitabine prodrug for treating cancer
@en
P2093
Abhinav P Acharya
Madhuri Dasari
Niren Murthy
Ross Molinaro
Seungjun Lee
P2860
P356
10.1021/BC300095M
P577
2012-12-26T00:00:00Z